(COV) Covivio - Ratings and Ratios

Covivio SA (PA:COV) is a leading European real estate player with a rich history of partnerships and a deep understanding of user needs. The company specializes in creating vibrant, functional spaces that integrate work, travel, and living, while fostering sustainable relationships and well-being. With €23 billion in assets under management, Covivio supports companies, hotel brands, and territories in enhancing their attractiveness and achieving responsible performance. Its purpose-driven approach emphasizes sustainability and long-term value creation for stakeholders, including customers, shareholders, employees, and future generations.

Covivio operates across key European markets, focusing on prime office assets, hotels, and mixed-use developments. Its portfolio is characterized by high-quality properties in major cities, with a strong emphasis on sustainability and tenant experience. The company’s shares are listed on Euronext Paris (Compartment A) and are included in several major indices, including MSCI, SBF 120, CAC Mid100, and Euronext IEIF ‘SIIC France.’ Covivio also holds top-tier ESG ratings, such as CDP (A), GRESB (88/100, 5-Star), and MSCI (AAA), reflecting its commitment to environmental, social, and governance standards.

Based on the provided and , Covivio’s stock is currently trading at €51.00, with a 20-day average volume of 156,092 shares. The stock has recently crossed above its 20-day SMA (€49.58) and 50-day SMA (€50.52), signaling potential short-term momentum. However, the 200-day SMA (€50.84) remains slightly above the current price, indicating a neutral long-term trend. The ATR of €1.45 suggests moderate volatility.

From a fundamental perspective, Covivio’s market cap stands at €5.63 billion, with a trailing P/E of 80.71 and a forward P/E of 11.33, suggesting expectations of future earnings growth. The P/B ratio of 0.68 indicates undervaluation relative to book value, while the P/S ratio of 5.03 reflects a premium for its revenue streams. However, the negative RoE of -14.54% raises concerns about profitability.

3-Month Forecast: - Technical Outlook: Expect COV to test the €52-€55 range in the next quarter, driven by the bullish crossover of the 20-day and 50-day SMAs. Support is likely at €49.50 (SMA 20) and resistance at €53.50 (SMA 200). - Fundamental Outlook: The stock may experience upward pressure due to its attractive forward P/E and strong ESG profile, but the high trailing P/E and negative RoE could limit significant upside. - Target Price: €55.00 by Q4 2023, contingent on improving profitability and maintaining its ESG leadership.